Rimola Jordi, Forner Alejandro, Reig Maria, Vilana Ramon, de Lope Carlos Rodríguez, Ayuso Carmen, Bruix Jordi
BCLC Group Radiology Department, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomédiques August Pi y Sunyer, University of Barcelona, Barcelona, Spain.
Hepatology. 2009 Sep;50(3):791-8. doi: 10.1002/hep.23071.
This study assesses the magnetic resonance (MR) features of intrahepatic cholangiocarcinoma (ICC) in patients with cirrhosis with specific analysis of the contrast enhancement pattern. Cholangiocarcinoma may show increased contrast uptake in the arterial phase, and, if washout in the delayed venous phase were to be detected, the noninvasive diagnostic criteria proposed in the American Association for the Study of Liver Diseases guidelines would be refuted. We reviewed the MR findings of 25 patients with cirrhosis with 31 histologically confirmed ICC nodules. Signal intensity on basal T1-weighted and T2-weighted images and characteristics of enhancement after contrast administration on arterial, portal, and delayed phase were registered. Enhancement pattern was defined according to the behavior of the lesions in each phase, and dynamic pattern was described according to the progression of enhancement throughout the different phases. The most frequent pattern displayed by ICC was a progressive contrast uptake (80.6%). Stable contrast enhancement was registered in 19.4%. None of the ICCs showed a washout pattern, a profile that is specific for hepatocellular carcinoma (HCC). The ICC dynamic behavior differed significantly according to tumor size: progressive enhancement pattern was the most frequent (20 of 25 cases) in lesions larger than 20 mm, whereas the stable pattern was mainly identified in nodules smaller than 20 mm. The most characteristic MR contrast pattern in ICC in cirrhosis is a progressive contrast uptake throughout the different phases, whereas contrast washout at delayed phases is not observed. Because stable enhancement pattern without washout also can be registered in small HCC nodules, the evaluation of delayed phase is mandatory for a proper nodule characterization. If washout is not registered, a biopsy should be mandatory for diagnosis.
本研究评估肝硬化患者肝内胆管癌(ICC)的磁共振(MR)特征,并对对比增强模式进行具体分析。胆管癌在动脉期可能表现为对比剂摄取增加,而如果在延迟静脉期检测到对比剂廓清,则美国肝病研究协会指南中提出的非侵入性诊断标准将被推翻。我们回顾了25例肝硬化患者的MR表现,其中有31个经组织学证实的ICC结节。记录了基础T1加权和T2加权图像上的信号强度以及动脉期、门静脉期和延迟期对比剂注射后的增强特征。根据各期病变的表现定义增强模式,并根据不同期增强的进展描述动态模式。ICC最常见的模式是对比剂渐进性摄取(80.6%)。稳定对比增强占19.4%。没有一个ICC表现出廓清模式,而廓清模式是肝细胞癌(HCC)的特异性表现。ICC的动态行为根据肿瘤大小有显著差异:在大于20 mm的病变中,渐进性增强模式最常见(25例中的20例),而稳定模式主要见于小于20 mm的结节。肝硬化患者ICC最具特征性的MR对比模式是在不同期均表现为对比剂渐进性摄取,而未观察到延迟期对比剂廓清。由于在小HCC结节中也可出现无廓清的稳定增强模式,因此对延迟期进行评估对于正确的结节特征性判断至关重要。如果未观察到廓清,诊断时应强制进行活检。